Kimberly Celotto


About Kimberly Celotto


Roswell Park Comprehensive Cancer Center

  • Physician Assistant
  • Department of Medicine


  • Celotto K, Lee K, Holstein S. End-Stage Myeloma with Extramedullary Plasmacytomas in the Era of Novel Therapies. AJHO. 2017, 13(2):21-23.
  • Celotto K, Neppalli V, Holstein, S Remarkable Response to Methylprednisone in a Multiple Myeloma Patient with Nodal Disease Refractory to High- Dose Chemotherapy. Cureus. 2015, 7(12): e411 PMID: 26824011
  • Ammannagari N, Celotto K, Neppalli V, Lee K, Holstein S Anaplastic Multiple Myeloma: An aggressive Variant with a Poor Response to Novel Therapies. CLML. 2016, 16 (9): e129-131 PMID:27375159
  • Baron J, Menon M, Hare R, Lund I, Mohr A, Rondeau C, Syta M, Celotto K, Iyer SP, Bhat S, Hernandez-Ilizaliturri F. Efficacy and safety of Dexamethasone, high dose cytarabine, and carboplatin (DHAC) with and without rituximab (R) as a salvage regimen for relapsed/refractory (R/R) lymphoma. J. Clin. Oncol.. 2016, 34: (suppl; abstr e19023)